These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7449273)

  • 21. Selective activation by LY-141865 and apomorphine of presynaptic dopamine receptors in the rat kidney and influence of stimulation parameters in the action of dopamine.
    Lokhandwala MF; Steenberg ML
    J Pharmacol Exp Ther; 1984 Jan; 228(1):161-7. PubMed ID: 6694099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart rate lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of central dopamine receptors leading to inhibition of sympathetic tone and enhancement of parasympathetic outflow.
    Cavero I; Lefèvre-Borg F; Gomeni R
    J Pharmacol Exp Ther; 1981 Nov; 219(2):510-9. PubMed ID: 6116802
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of peripheral dopamine receptor and alpha-adrenoceptor blocking activity of sulpiride.
    Barrett RJ; Ginos JZ; Lokhandwala MF
    Eur J Pharmacol; 1982 Apr; 79(3-4):273-81. PubMed ID: 6124431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of central dopamine (DA) receptors in the regulation of blood pressure.
    Jaszlits L; Tardos L; Borsy J
    Pol J Pharmacol Pharm; 1985; 37(3):405-10. PubMed ID: 4070082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of central dopamine receptors in the hypotensive action of pergolide.
    Jadhav AL; Willett RN; Sapru HN; Lokhandwala MF
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):281-6. PubMed ID: 6664381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration in ocular function induced by phenylethylamine analogs of dopamine.
    Potter DE; Burke JA; Chang FW
    Curr Eye Res; 1984 Jun; 3(6):851-9. PubMed ID: 6329603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presynaptic dopamine receptors mediate the inhibitory action of dopamine agonists on stimulation-evoked pressor responses in the rat.
    Clapham JC; Hamilton TC
    J Auton Pharmacol; 1982 Sep; 2(3):181-8. PubMed ID: 7142233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of the antihypertensive action of DL-alpha-monofluoromethyldopa: implications for the role of the sympathetic nervous system in maintenance of elevated blood pressure in spontaneously hypertensive rats.
    Fozard JR; Möhring J; Palfreyman MG; Koch-Weser J
    J Cardiovasc Pharmacol; 1981; 3(5):1038-49. PubMed ID: 6168849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flavodilol: a new antihypertensive agent.
    Kinsolving CR; Watkins BE; Borrelli AR; Kaiser FC; Wu ES
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):127-41. PubMed ID: 2475704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of spinal dopamine receptors to the hypotensive action of bromocriptine in rats.
    Lahlou S; Demenge P
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):317-25. PubMed ID: 1720830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of peripheral dopamine receptors in the antihypertensive effect of a new ergoline derivative (355/1057).
    Salvati P; Bianchi G
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):291-304. PubMed ID: 4026460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist.
    Kohli JD; Goldberg LI; Volkman PH; Cannon JG
    J Pharmacol Exp Ther; 1978 Oct; 207(1):16-22. PubMed ID: 702336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats.
    Bayorh MH; Zukowska-Grojec Z; Kopin IJ; Feuerstein G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):85-90. PubMed ID: 6491978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha 1/alpha 2-adrenoceptor agonist selectivity of mono- and dihydroxy-2-N,N-DI-n-propylaminotetralins.
    Timmermans PB; Mathy MJ; Wilffert B; Kalkman HO; Smit G; Dijkstra D; Horn AS; Van Zwieten PA
    Eur J Pharmacol; 1984 Jan; 97(1-2):55-65. PubMed ID: 6321211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the cardiovascular effects of co-derocrine (Hydergine).
    Clark BJ; Bucher T; Waite R
    J Pharmacol; 1985; 16 Suppl 3():101-11. PubMed ID: 2869189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flavodilol: a new antihypertensive agent that preferentially depletes peripheral biogenic amines.
    Blosser JC; McCreedy S; Parker RB; Kinsolving CR; Watkins BE; Wu ES
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):142-56. PubMed ID: 2475706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypotensive action and alpha-adrenolytic properties of a new dopaminergic agonist, CU 32-085, in the rat.
    Morales-Olivas FJ; Palop V; Rubio E; Esplugues J
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):71-8. PubMed ID: 6151381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Release of catecholamines in the locus coeruleus of freely moving and anaesthetized normotensive and spontaneously hypertensive rats: effects of cardiovascular changes and tail pinch.
    Kaehler ST; Sinner C; Philippu A
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):433-9. PubMed ID: 10763859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Centrally mediated antihypertensive and bradycardic effects of methysergide in spontaneously hypertensive rats.
    Antonaccio MJ; Coté D
    Eur J Pharmacol; 1976 Apr; 36(2):451-4. PubMed ID: 1278233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presynaptic dopamine receptors and alpha-adrenoceptors as mediators of the bradycardic action of N-n-propyl-N-n-butyl dopamine.
    Hamed AT; Jandhyala BS; Ginos JZ; Lokhandwala MF
    Eur J Pharmacol; 1981 Aug; 74(1):83-90. PubMed ID: 6119207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.